Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials. [electronic resource]
Producer: 20190611Description: 47 p. digitalISSN:- 1475-2840
- Cardiovascular Diseases -- diagnosis
- Diabetes Mellitus -- diagnosis
- Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
- Humans
- Hypoglycemic Agents -- adverse effects
- Incretins -- therapeutic use
- Protective Agents
- Randomized Controlled Trials as Topic
- Risk Assessment
- Risk Factors
- Sodium-Glucose Transporter 2 Inhibitors -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.